Advances in the role of interferon-induced proteins with tetratricopeptide repeats(TPR) in digestive system tumors

Abstract

CLC Number:

R735

ZHANG Yue-yi, LI Mei-zi, YANG Ying-yun, YANG Ai-ming. Advances in the role of interferon-induced proteins with tetratricopeptide repeats(TPR) in digestive system tumors[J]. Basic & Clinical Medicine, 2021, 41(11): 1662-1665.

References

[1]Feng CX, Hong XS, Bei YA, et al. NF-κB-dependent IFIT3 induction by HBx promotes hepatitis B virus replication[J]. Front Microbiol, 2019, 10: 2382. doi: 10.3389/fmicb.2019.02382.
[2]Yuji I, Masakazu K, Bo-Ram B, et al. Hepatic IFN-induced protein with tetratricopeptide repeats regulation of HCV infection[J]. J Interferon Cytokine Res, 2019, 39: 133-146.
[3]Britney J, Laura B, Wei X, et al. Binding of IFIT1 by IFIT3 modulates protein stability and RNA binding specificity[J]. Immunity, 2018, 48: 487-499.
[4]Renata CF, Harriet VM, Xin YL, et al. IFIT3 and IFIT2/3 promote IFIT1-mediated translation inhibition by enhancing binding to non-self RNA[J]. Nucleic Acids Res, 2018, 46: 5269-5285.
[5]Nathan B, Cornelia H, Roy K, et al. Intrinsic disorder in tetratricopeptide repeat proteins[J]. Int J Mol Sci, 2020, 21: 3709. doi: 10.3390/ijms21103709.
[6]Pidugu VK, Wu MM, Yen AH, et al. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling[J]. Oncogene, 2019, 38: 3232-3247.
[7]Yang YY, Zhou Y, Hou J, et al. Hepatic IFIT3 predicts interferon-alpha therapeutic response in patients of hepatocellular carcinoma[J]. Hepatology, 2017, 66: 152-166.
[8]Stawowczyk M, Van SS, Kumar KP, et al. The interferon stimulated gene 54 promotes apoptosis[J]. J Biol Chem, 2011, 286: 7257-7266.
[9]Hsu YA, Lin HJ, Sheu JJ, et al. A novel interaction between interferon-inducible protein p56 and ribosomal protein L15 in gastric cancer cells[J]. DNA Cell Biol, 2011, 30: 671-679.
[10]Jia H, Song L, Cong Q, et al. The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1/STAT1/IFIT2 network[J]. Oncogene, 2017, 36: 2655-2666.
[11]Li D, Sun JJ, Liu WF, et al. Rig-G is a growth inhibitory factor of lung cancer cells that suppresses STAT3 and NF-κB[J]. Oncotarget, 2016, 7: 66032-66050.
[12]Niess H, Camaj P, Mair R, et al. Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular “pseudoinflammation” contributing to an aggressive phenotype[J]. Oncotarget, 2015, 20: 3306-3318.
[13]Li SX, Liu FL, Xu L, et al. Wnt/β-Catenin signaling axis is required for TFEB-mediated gastric cancer metasta-sis and epithelial-mesenchymal transition[J]. Mol Cancer Res, 2020.doi:10.1158/1541-7786.MCR-20-0180.
[14]Sylvanus K, Bulbul A, Zhou TT, et al. Scorpion venom analgesic peptide, BmK AGAP inhibits stemness, and epithelial-mesenchymal transition by down-regulating PTX3 in breast cancer[J]. Front Oncol, 2019, 9: 21. doi: 10.3389/fonc.2019.00021. eCollection 2019.
[15]Lai KC, Liu CJ, Chang KW, et al. Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells[J]. Oncogene, 2013, 32: 3686-3697.
[16]Chen L, Liu S, Xu F, et al. Inhibition of proteasome activity induces aggregation of IFIT2 in the centrosome and enhances IFIT2-induced cell apoptosis[J]. Int J Biol Sci, 2017, 13: 383-390.
[17]Zhang BH, Tang BF, Gao JY, et al. A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients[J]. J Transl Med, 2020, 18: 342. doi: 10.1186/s12967-020-02492-9.
[18]Andreas AH, Ulf G, Christine G, et al. IL7-IL12 engineered mesenchymal stem cells (MSCs) improve a CART cell attack against colorectal cancer cells[J]. Cells, 2020, 9: 873. doi: 10.3390/cells9040873.
[19]KIM W, KHAN SK, LIU Y, et al. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma[J]. Gut, 2018, 67:1692-1703.
[20]Wang JH, Dai M, Cui YG, et al. Association of abnormal elevations in IFIT3 with overactive cyclic GMP-AMP synthase/stimulator of interferon genes signaling in human systemic lupus erythematosus monocytes[J]. Arthritis Rheumatol, 2018, 70: 2036-2045.
[21]Chen LJ, Zhai WS, Zheng X, et al. Decreased IFIT2 expression promotes gastric cancer progression and predicts poor prognosis of the patients[J]. Cell Physiol Biochem, 2018, 45: 15-25.
[22]Zhao Y, Altendorf-Hofmann A, Pozios I, et al. Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma[J]. J Cancer Res Clin Oncol, 2017, 143: 1061-1068.